Company news

Tectonic Therapeutic, Inc. news in 2025

Tectonic Therapeutic, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Tectonic Therapeutic to Participate in December Investor Conferences

December 1, 2025

Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights

November 6, 2025

Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF

October 29, 2025

Tectonic Therapeutic to Participate in September Investor Conferences

August 28, 2025

Tectonic Therapeutic Announces Second Quarter 2025 Financial Results and Recent Business Highlights

August 7, 2025

Tectonic Therapeutic Joins Russell 3000® Index

June 30, 2025

Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025

May 17, 2025

Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights

May 8, 2025

Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference

May 7, 2025

Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025

April 15, 2025

Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

March 20, 2025

Tectonic Therapeutic to Participate in March Investor Conferences

February 20, 2025

Tectonic Announces $185 Million Private Placement

February 2, 2025

Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF

January 29, 2025

Decks in 2025